Cargando…

Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts

BACKGROUND: To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymer...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollock, Nira R, Tran, Kristine, Jacobs, Jesica R, Cranston, Amber E, Smith, Sita, O’Kane, Claire Y, Roady, Tyler J, Moran, Anne, Scarry, Alison, Carroll, Melissa, Volinsky, Leila, Perez, Gloria, Patel, Pinal, Gabriel, Stacey, Lennon, Niall J, Madoff, Lawrence C, Brown, Catherine, Smole, Sandra C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244626/
https://www.ncbi.nlm.nih.gov/pubmed/34250188
http://dx.doi.org/10.1093/ofid/ofab243
_version_ 1783715968221970432
author Pollock, Nira R
Tran, Kristine
Jacobs, Jesica R
Cranston, Amber E
Smith, Sita
O’Kane, Claire Y
Roady, Tyler J
Moran, Anne
Scarry, Alison
Carroll, Melissa
Volinsky, Leila
Perez, Gloria
Patel, Pinal
Gabriel, Stacey
Lennon, Niall J
Madoff, Lawrence C
Brown, Catherine
Smole, Sandra C
author_facet Pollock, Nira R
Tran, Kristine
Jacobs, Jesica R
Cranston, Amber E
Smith, Sita
O’Kane, Claire Y
Roady, Tyler J
Moran, Anne
Scarry, Alison
Carroll, Melissa
Volinsky, Leila
Perez, Gloria
Patel, Pinal
Gabriel, Stacey
Lennon, Niall J
Madoff, Lawrence C
Brown, Catherine
Smole, Sandra C
author_sort Pollock, Nira R
collection PubMed
description BACKGROUND: To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. METHODS: Consenting symptomatic and asymptomatic children (≤18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitoring. All tests had 2 independent reads to assess interoperator agreement. Patients with positive CareStart results were called and instructed to isolate pending RT-PCR results. The paired RT-PCR result was the reference for sensitivity and specificity calculations. RESULTS: Of 1603 participants, 1245 adults and 253 children had paired RT-PCR/CareStart results and complete symptom data. Eighty-three percent of adults and 87% of children were asymptomatic. CareStart sensitivity/specificity were 84.8% (95% confidence interval [CI], 71.1–93.7)/97.2% (95% CI, 92.0–99.4) and 85.7% (95% CI, 42.1–99.6)/89.5% (95% CI, 66.9–98.7) in adults and children, respectively, within 5 days of symptoms. Sensitivity/specificity were 50.0% (95% CI, 41.0–59.0)/99.1% (95% CI, 98.3–99.6) in asymptomatic adults and 51.4% (95% CI, 34.4–68.1)/97.8% (95% CI, 94.5–99.4) in asymptomatic children. Sensitivity in all 234 RT-PCR-positive people was 96.3% with cycle threshold (Ct) ≤25, 79.6% with Ct ≤30, and 61.4% with Ct ≤35. All 21 false-positive CareStart tests had faint but normal bands. Interoperator agreement was 99.5%. Operational challenges included identification of faint test bands and inconsistent swab elution volumes. CONCLUSIONS: CareStart had high sensitivity in people with Ct ≤25 and moderate sensitivity in symptomatic people overall. Specificity was unexpectedly lower in symptomatic versus asymptomatic people. Excellent interoperator agreement was observed, but operational challenges indicate that operator training is warranted.
format Online
Article
Text
id pubmed-8244626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-82446262021-07-01 Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts Pollock, Nira R Tran, Kristine Jacobs, Jesica R Cranston, Amber E Smith, Sita O’Kane, Claire Y Roady, Tyler J Moran, Anne Scarry, Alison Carroll, Melissa Volinsky, Leila Perez, Gloria Patel, Pinal Gabriel, Stacey Lennon, Niall J Madoff, Lawrence C Brown, Catherine Smole, Sandra C Open Forum Infect Dis Major Articles BACKGROUND: To facilitate deployment of point-of-care testing for severe acute respiratory syndrome coronavirus 2, we evaluated the Access Bio CareStart COVID-19 Antigen test in a high-throughput, drive-through, free community testing site using anterior nasal (AN) swab reverse-transcription polymerase chain reaction (RT-PCR) for clinical testing. METHODS: Consenting symptomatic and asymptomatic children (≤18 years) and adults received dual AN swabs. CareStart testing was performed with temperature/humidity monitoring. All tests had 2 independent reads to assess interoperator agreement. Patients with positive CareStart results were called and instructed to isolate pending RT-PCR results. The paired RT-PCR result was the reference for sensitivity and specificity calculations. RESULTS: Of 1603 participants, 1245 adults and 253 children had paired RT-PCR/CareStart results and complete symptom data. Eighty-three percent of adults and 87% of children were asymptomatic. CareStart sensitivity/specificity were 84.8% (95% confidence interval [CI], 71.1–93.7)/97.2% (95% CI, 92.0–99.4) and 85.7% (95% CI, 42.1–99.6)/89.5% (95% CI, 66.9–98.7) in adults and children, respectively, within 5 days of symptoms. Sensitivity/specificity were 50.0% (95% CI, 41.0–59.0)/99.1% (95% CI, 98.3–99.6) in asymptomatic adults and 51.4% (95% CI, 34.4–68.1)/97.8% (95% CI, 94.5–99.4) in asymptomatic children. Sensitivity in all 234 RT-PCR-positive people was 96.3% with cycle threshold (Ct) ≤25, 79.6% with Ct ≤30, and 61.4% with Ct ≤35. All 21 false-positive CareStart tests had faint but normal bands. Interoperator agreement was 99.5%. Operational challenges included identification of faint test bands and inconsistent swab elution volumes. CONCLUSIONS: CareStart had high sensitivity in people with Ct ≤25 and moderate sensitivity in symptomatic people overall. Specificity was unexpectedly lower in symptomatic versus asymptomatic people. Excellent interoperator agreement was observed, but operational challenges indicate that operator training is warranted. Oxford University Press 2021-05-26 /pmc/articles/PMC8244626/ /pubmed/34250188 http://dx.doi.org/10.1093/ofid/ofab243 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Pollock, Nira R
Tran, Kristine
Jacobs, Jesica R
Cranston, Amber E
Smith, Sita
O’Kane, Claire Y
Roady, Tyler J
Moran, Anne
Scarry, Alison
Carroll, Melissa
Volinsky, Leila
Perez, Gloria
Patel, Pinal
Gabriel, Stacey
Lennon, Niall J
Madoff, Lawrence C
Brown, Catherine
Smole, Sandra C
Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
title Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
title_full Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
title_fullStr Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
title_full_unstemmed Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
title_short Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
title_sort performance and operational evaluation of the access bio carestart rapid antigen test in a high-throughput drive-through community testing site in massachusetts
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244626/
https://www.ncbi.nlm.nih.gov/pubmed/34250188
http://dx.doi.org/10.1093/ofid/ofab243
work_keys_str_mv AT pollocknirar performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT trankristine performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT jacobsjesicar performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT cranstonambere performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT smithsita performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT okaneclairey performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT roadytylerj performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT morananne performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT scarryalison performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT carrollmelissa performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT volinskyleila performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT perezgloria performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT patelpinal performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT gabrielstacey performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT lennonniallj performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT madofflawrencec performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT browncatherine performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts
AT smolesandrac performanceandoperationalevaluationoftheaccessbiocarestartrapidantigentestinahighthroughputdrivethroughcommunitytestingsiteinmassachusetts